EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject_exact:"Pharmaceutical Industry"
Narrow search

Narrow search

Year of publication
Subject
All
Pharmaceutical industry 7,577 Pharmaindustrie 7,333 Arzneimittel 2,798 Pharmaceuticals 2,773 Arzneimittelmarkt 1,286 Pharmaceutical market 1,219 Innovation 941 USA 893 United States 860 India 737 Pharmazeutische Industrie 728 Indien 717 Pharmakologie 709 Pharmacology 704 Welt 631 World 631 Deutschland 623 Patent 602 Germany 583 Theorie 553 Theory 553 Industrieforschung 483 Industrial research 479 Innovationsmanagement 404 Innovation management 385 pharmaceutical industry 363 Gesundheitswesen 359 Biotechnology industry 349 Biotechnologie-Industrie 345 Generic drugs 341 Generika 336 Health care system 335 Multinationales Unternehmen 329 Intellectual property rights 322 Patentrecht 322 Regulierung 321 Patent law 320 Immaterialgüterrechte 319 Regulation 317 Lieferkette 312
more ... less ...
Online availability
All
Free 2,388 Undetermined 1,670 CC license 116
Type of publication
All
Book / Working Paper 4,101 Article 4,091 Journal 77 Other 6
Type of publication (narrower categories)
All
Article in journal 2,926 Aufsatz in Zeitschrift 2,926 Graue Literatur 999 Non-commercial literature 999 Aufsatz im Buch 757 Book section 757 Working Paper 680 Arbeitspapier 667 Hochschulschrift 351 Thesis 278 Case study 212 Fallstudie 212 Collection of articles of several authors 163 Sammelwerk 163 Aufsatzsammlung 89 Bibliografie enthalten 63 Bibliography included 63 Konferenzschrift 58 Dissertation u.a. Prüfungsschriften 56 research-article 52 Amtsdruckschrift 50 Government document 50 Conference proceedings 34 Business report 31 Geschäftsbericht 31 No longer published / No longer aquired 28 Article 25 Market information 25 Marktinformation 25 Conference paper 20 Konferenzbeitrag 20 case-report 20 Collection of articles written by one author 19 Sammlung 19 Statistik 16 Festschrift 15 Lehrbuch 15 Statistics 13 review-article 13 Bibliografie 12
more ... less ...
Language
All
English 6,724 German 947 Undetermined 367 French 100 Spanish 49 Italian 38 Russian 20 Portuguese 13 Hungarian 6 Polish 5 Swedish 5 Dutch 4 Croatian 3 Arabic 1 Danish 1 Finnish 1 Japanese 1 Kazakh 1 Norwegian 1 Romanian 1 Slovenian 1 Turkish 1 Ukrainian 1
more ... less ...
Author
All
Berndt, Ernst R. 45 Lichtenberg, Frank R. 43 Higgins, Matthew J. 35 Riccaboni, Massimo 34 Pammolli, Fabio 32 Danzon, Patricia Munch 29 Rudholm, Niklas 27 Cockburn, Iain 26 Orsenigo, Luigi 24 Vernon, John A. 24 Henderson, Rebecca 22 Scherer, Frederic M. 22 Grabowski, Henry G. 21 Granlund, David 21 Sampat, Bhaven N. 21 Chatterjee, Chirantan 20 Lakdawalla, Darius 20 Azoulay, Pierre 19 Mehralian, Gholamhossein 18 Scott Morton, Fiona 18 Ceccagnoli, Marco 17 Golec, Joseph 17 Harms, Fred 17 Kyle, Margaret K. 17 Nicholson, Sean 17 Phlippen, Sandra 17 Dubois, Pierre 16 McGuire, Thomas G. 16 Philipson, Tomas J. 16 Brekke, Kurt R. 15 Comanor, William S. 15 Li, Danielle 15 Newham, Melissa 15 Seldeslachts, Jo 15 Siebert, Ralph 15 Kale, Dinar 14 Ornaghi, Carmine 14 Towse, Adrian 14 Abbott, Frederick M. 13 Ahlert, Dorothee 13
more ... less ...
Institution
All
National Bureau of Economic Research 116 OECD 27 eSocialSciences 14 European Commission / Directorate-General for Health and Food Safety 11 Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München 11 United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT) 10 Bundesverband der Pharmazeutischen Industrie 9 Springer Fachmedien Wiesbaden 9 Europäische Kommission 8 Verband Forschender Arzneimittelhersteller 8 Edward Elgar Publishing 7 Interpharma 7 Université Paris-Dauphine (Paris IX) 7 Department of Economics and Business, Universitat Pompeu Fabra 6 United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology 6 World Bank 6 World Trade Organization 6 Großbritannien / Office of Health Economics 5 UNCTAD / Secretariat 5 UNIDO 5 American Enterprise Institute for Public Policy Research 4 Economists Advisory Group 4 European Commission / Directorate-General for Migration and Home Affairs 4 European Monitoring Centre for Drugs and Drug Addiction 4 European Parliament / Directorate-General for Internal Policies of the Union 4 F. Hoffmann-La Roche AG 4 Fraunhofer-Institut für Systemtechnik und Innovationsforschung 4 Institutionen för Nationalekonomi, Umeå Universitet 4 Medizinisch-Pharmazeutische Studiengesellschaft 4 Novartis AG 4 Organisation for Economic Co-operation and Development 4 UNCTAD 4 United Nations Conference on Trade and Development 4 Association of the British Pharmaceutical Industry 3 Centre for Health Economics, Department of Economics and Related Studies 3 Centre for Innovation, Research and Competence in the Learning Economy (CIRCLE), Lunds Universitet 3 Department of Economics and Finance, College of Business and Economics 3 Economics Group, Business School 3 Economics, Markets, Institutions, IMT Lucca Institute for Advanced Studies 3 Esomar 3
more ... less ...
Published in...
All
NBER working paper series 116 NBER Working Paper 89 Working paper / National Bureau of Economic Research, Inc. 77 International journal of pharmaceutical and healthcare marketing : IJPHM 70 Journal of medical marketing : device, diagnostic and pharmaceutical marketing 67 Research policy : policy, management and economic studies of science, technology and innovation 56 Journal of health economics 52 SpringerLink / Bücher 52 The European journal of health economics : HEPAC ; health economics in prevention and care 46 Technology analysis & strategic management 38 International journal of the economics of business 35 Health economics 31 International journal of technology management : IJTM 31 Management science : journal of the Institute for Operations Research and the Management Sciences 29 Industrial and corporate change 28 Research paper 28 Europäische Hochschulschriften / 5 27 PharmacoEconomics 27 Health marketing quarterly 26 Strategic management journal 25 Technological forecasting & social change : an international journal 25 Managerial and decision economics : MDE ; the international journal of research and progress in management economics 23 Pharmaceutical markets and insurance worldwide 23 Journal of business ethics : JOBE 22 Pharmamarketing : gesundheitsökonomische Aspekte einer innovativen Industrie am Beispiel von Deutschland, Österreich und der Schweiz 21 International journal of pharmaceutical and healthcare marketing 20 R & D management 19 International journal of industrial organization 18 International journal of production economics 18 Working paper 18 Applied economics 17 Journal of business research : JBR 17 Gabler Edition Wissenschaft 16 International journal of production research 16 Technovation : the international journal of technological innovation, entrepreneurship and technology management 15 European journal of operational research : EJOR 14 Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies 14 Organization science : a journal of the Institute for Operations Research and the Management Sciences ; bridging disciplines to advance knowledge of organizations 14 Working Papers / eSocialSciences 14 Academy of Management journal : AMJ 13
more ... less ...
Source
All
ECONIS (ZBW) 7,519 RePEc 354 USB Cologne (EcoSocSci) 219 Other ZBW resources 108 EconStor 45 BASE 25 ArchiDok 5
more ... less ...
Showing 1 - 50 of 8,275
Cover Image
Efficiency and super-efficiency in the CRO industry, 2012-2021 : a two-stage exploration
Díaz, Ricardo F.; Sánchez-Robles Rute, Blanca - In: Managerial and decision economics : MDE ; the … 46 (2025) 2, pp. 810-831
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376857
Saved in:
Cover Image
Operations management in the pharmaceutical industry
Anand, Gopesh; Ball, George P.; Gray, John V.; … - In: Journal of operations management 71 (2025) 3, pp. 302-313
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376789
Saved in:
Cover Image
Supply base attributes and diversion risk in a supply chain for hazardous pharmaceutical products
Skilton, Paul F.; Mackelprang, Alan; Sepehrirad, Ramin; … - In: Journal of operations management 71 (2025) 3, pp. 373-392
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376815
Saved in:
Cover Image
Supply chain disruptions during COVID-19 pandemic : key lessons from the pharmaceutical industry
Takawira, Blessing; Pooe, Raborale I. D. - In: South African journal of business management 55 (2024) 1, pp. 1-10
Purpose: This study extends previous research by exploring the key lessons learned by the pharmaceutical industry in South Africa from the COVID-19 pandemic supply chain disruptions. Design/methodology/approach: Having embraced the interpretivist paradigm, 25 supply chain professionals were...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015196528
Saved in:
Cover Image
Strategic imperatives for digitisation of the Ukrainian pharmaceutical industry
Safonov, Yuriy; Korotun, Olha; Khmurova, Viktoriia - In: Baltic Journal of Economic Studies 10 (2024) 2, pp. 238-251
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015152961
Saved in:
Cover Image
Sustaining the integration of social objectives over time : a case-based analysis of access to medicine in the pharmaceutical industry
Bünder, Tobias; Rathert, Nikolas; Mair, Johanna - In: Business & society 63 (2024) 5, pp. 1110-1148
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014577841
Saved in:
Cover Image
Dusting off the old ones : drug licensing to startups, innovation success and efficiency
Hammoudeh, Mosab; Krieger, Joshua L.; Xu, Jiajie - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014529873
Saved in:
Cover Image
The role of Information Technology and employee engagement in enhancing Knowledge Management in the pharmaceutical Research and Development process : insights from dynamic capabilities theory
Chatzifoti, Natalia; Didaskalou, Eleni A.; Chountalas, … - In: Businesses 4 (2024) 3, pp. 315-330
This study investigates the impact of Information Technology and employee engagement on the implementation of Knowledge Management within the Research and Development processes of pharmaceutical companies. Based on Dynamic Capabilities Theory, this research examines the interaction between these...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015098513
Saved in:
Cover Image
MSD : continuous pharmaceutical manufacturing data for the 2024 MSOM Data-Driven Research Challenge
Martagan, Tugce; Baaijens, Marc; Dirckx, Coen; Holman, James - In: Manufacturing & service operations management : M & SOM 26 (2024) 5, pp. 1587-1604
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015130716
Saved in:
Cover Image
Analysis of trends in the development of the pharmaceutical market of Ukraine in 2007-2021
Mashchenko, Olga; Serhieieva, Lyudmila; Shyshka, Іhor - In: Baltic Journal of Economic Studies 9 (2023) 3, pp. 145-150
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015141689
Saved in:
Cover Image
The impact of firm-based organizational citizenship behavior on continuance and normative commitment among pharmaceutical executives : an SEM approach
Oamen, Theophilus Ehidiamen - In: Journal of economics & management 45 (2023) 1, pp. 47-67
Aim/purpose - The study was based on social exchange theory and addressed the effects of firm-based organizational citizenship behavior (OCB) on normative and continuance organizational commitment (OC). Multigroup behavioral differences among pharmaceutical executives were also evaluated....
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014325196
Saved in:
Cover Image
Does uncertainty boost exports? : a study on the effect of innovation and marketing capabilities in a small and innovation-intensive sector
Vieira, Jorge; Frade, Rui; Martinho, Filipa; Martinho, … - In: Economies : open access journal 11 (2023) 1, pp. 1-20
The main goal of this research is to study the impact of uncertainty on export performance, from a resource-based perspective. Despite the ample research on how economies behave during periods of high uncertainty, there is still a poor understanding of how this affects smaller sectors,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013500906
Saved in:
Cover Image
Covid-19 and the South African pharmaceutical supply chain : drivers, strategies, and recommendations
Takawira, Blessing; Pooe, David Rabolane Isaac - 2023
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014452622
Saved in:
Cover Image
A strategic response to COVID-19 induced supply chain disruption in South Africa's pharmaceutical industry
Takawira, Blessing; Mutambara, Emmanuel - 2023
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014452636
Saved in:
Cover Image
Integrated shelf-life rules for multi-level pharmaceutical tablets manufacturing processes
Simonis, Michael; Nickel, Stefan - In: International journal of production research 63 (2025) 3, pp. 1046-1066
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015198531
Saved in:
Cover Image
The threat of pharmaceutical crime in the EU and beyond
European Union Agency for Law Enforcement Cooperation - 2025
This report outlines the threat of pharmaceutical crime in the EU and beyond, as assessed by Europol. It aims to raise awareness of the ways criminal networks exploit consumers and industry in generating illegal revenue through producing and selling counterfeit medicines.
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015322789
Saved in:
Cover Image
Can the size and duration of clinical trials in new drug applications predict post-approval safety warnings?
Clark, Jeremy; Menclova, Andrea Kutinova - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394355
Saved in:
Cover Image
Evaluating quality reward and other interventions to mitigate US drug shortages
Naumov, Sergey; Noh, In Joon; Zhao, Hui - In: Journal of operations management 71 (2025) 3, pp. 335-372
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015376804
Saved in:
Cover Image
Combating vaccine hesitancy : the case of HPV vaccination
Díaz, Lina; Villarreal, Deborah Martínez; Márquez, Karina - 2025
Cervical cancer, primarily caused by persistent Human Papillomavirus (HPV) infection, remains one of the leading causes of cancer-related deaths among women in developing countries. Although HPV vaccines are widely available in these regions, vaccine uptake remains persistently low. To address...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015271625
Saved in:
Cover Image
An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines : evidence from 35 countries
Leon, Giovanny; Carbonel, Christophe; Rampuria, Aparajit; … - In: The European journal of health economics 26 (2025) 3, pp. 513-536
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394765
Saved in:
Cover Image
Role of pharmacists in generic pharmaceutical adoption
Kakehi, Haruo; Nakajima, Ryo - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015187356
Saved in:
Cover Image
Evaluation of a partial ban of Rx-rebates in Germany using difference-in-differences
Gail, Maximilian M.; Goetz, Georg; Herold, Daniel; … - 2025
In December 2020, Germany implemented a policy restricting online pharmacies from offering rebates on prescription drugs to members of the statutory health insurance. This policy change created a natural experiment, allowing us to analyze its impact on the pharmaceutical market using...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015202669
Saved in:
Cover Image
Application de l'exception Bolar : différentes approches dans le droit de l'UE
Doubinsky, Dmytro - 2025
This Research Paper addresses the growing problem of access to essential medicines, focusing on the role of intellectual property rights, particularly patent rights, in restricting access by enabling pharmaceutical market monopolies that keep drug prices high. The paper explores the Bolar...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015358929
Saved in:
Cover Image
The EU community pharmacy market : the density and its influencing factors
Schwaabe, Selina - 2025
Community pharmacies deliver high-quality health care and are responsible for medication safety. The goal of the government is to ensure nationwide, accessible, and affordable medical health-care services provided by pharmacies. Therefore, the per capita density of community pharmacies matters....
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015211718
Saved in:
Cover Image
What economists should know about the 340B Drug Discounting Program
Courtemanche, Charles; Garuccio, Joseph - 2025
The 340B Drug Pricing Program was instituted to bolster the health care safety net without relying on taxpayer money. It allows participating health care facilities - most of which are hospitals - to purchase drugs filled at in-house or contracted external pharmacies at discounts from...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015395374
Saved in:
Cover Image
Passthrough of retail price regulation in the market for pharmaceuticals
Jaakko, Markkanen - 2025
I study the passthrough of regulated ad valorem pharmacy markups and reduced Value Added Tax (VAT) rates to pharmaceutical retail prices in Finland. My reduced form evidence shows that pharmaceutical manufacturers respond to a decrease in regulated pharmacy markups by increasing their wholesale...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015173440
Saved in:
Cover Image
Exploring corporate capital structure and overleveraging in the pharmaceutical industry
Issa, Samar; Issa, Hussein - In: Risks : open access journal 13 (2025) 2, pp. 1-33
This paper applies an empirical model of corporate capital structure, optimal debt, and overleveraging to estimate overleveraging measured as the difference between actual and optimal debt. Estimated using a sample of the twenty largest pharmaceutical firms, covering the time span from 2000 to...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015333730
Saved in:
Cover Image
Greening the pharmaceutical supply chain
Belal, Md Mostain; Shukla, Vinaya; Sreejith Balasubramanian - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015357789
Saved in:
Cover Image
Long-term performance of technology acquisitions : the role of acquisition program diversity, innovation, and alliance portfolio size : evidence from the pharmaceutical industry
Schweizer, Lars; Wang, Le; Koscher, Eva - In: European management journal 43 (2025) 1, pp. 154-168
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015333120
Saved in:
Cover Image
Information technology, improved access, and use of prescription drugs
Böckerman, Petri; Kortelainen, Mika; Laine, Liisa T.; … - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015357201
Saved in:
Cover Image
Technological autonomy or global integration : navigating vaccine dependency in LMICs
Marin, Anabel; Morales, Jose - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394620
Saved in:
Cover Image
Significance of intellectual capital measurement : an investigation of the Bangladesh pharmaceutical industry
Jisun, Tahsin Farzana; Devika Nadarajah; Md. Yasin, Ida; … - In: International journal of learning and intellectual capital 21 (2024) 6, pp. 668-708
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015272732
Saved in:
Cover Image
Patient-centricity in the pharmaceutical industry : a review and research agenda
Fleissig, Jordan; Delcourt, Cécile; Steils, Nadia - In: International journal of consumer studies 49 (2025) 1, pp. 1-25
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015333779
Saved in:
Cover Image
Innovation for development : the key to a transformative recovery in Latin America and the Caribbean : third meeting of the Conference on Science, Innovation and Information and Communications Technologies of the Economic Commission for Latin America and the Caribbean : virtual meeting, 13-15 December 2021
Meeting of the Conference on Science, Innovation and …; … - 2022
Science, innovation, knowledge and digital technologies have played a fundamental role in the growth potential, social inclusion and environmental sustainability of countries in recent decades, and have become even more important in the context of the crisis caused by the coronavirus disease...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013329594
Saved in:
Cover Image
Developing a system dynamic model for product life cycle management of generic pharmaceutical products : its relation with open innovation
Mousavi, Atefeh; Mohammadzadeh, Mehdi; Zare, Hossein - In: Journal of open innovation : technology, market, and … 8 (2022) 1, pp. 1-19
The purpose of this study is to identify elements that influence the sale of generic pharmaceutical products during their life cycle in order to achieve more comprehensive planning and to prevent a decline stage of the product life cycle (PLC). We used a system dynamic model to identify the...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10012801597
Saved in:
Cover Image
A structural analysis of unemployment-generating supply shocks with an application to the US pharmaceutical industry
Boni, Sara; Ravazzolo, Francesco - 2022
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013366761
Saved in:
Cover Image
Ambidexterity's influence on export strategy development : the case of the Indian pharmaceutical industry
Kolte, Ashutosh; Festa, Giuseppe; Rossi, Matteo; … - In: Thunderbird international business review 64 (2022) 5, pp. 465-476
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013414197
Saved in:
Cover Image
Industrial and organizational mutations in the medical and pharmaceutical sectors impulsed by open innovation during the pandemic
Adatto, Laurent; Aouinait, Camille; Le Son Thi Kim; … - In: Proceedings of the ENTRENOVA - ENTerprise REsearch … 8 (2022) 1, pp. 421-434
The Covid-19 pandemic tragically emphasized severe failures of health systems. In particular, the saturation of hospital infrastructures and the lack of medical devices is crucial for respiratory ventilators. The medical and pharmaceutical sectors had to find urgently new ways to innovate...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014308369
Saved in:
Cover Image
Employee compensation, training and financial performance during the COVID-19 pandemic
Mahssouni, Rabie; Touijer, Mohamed Noureddine; … - In: Journal of risk and financial management : JRFM 15 (2022) 12, pp. 1-19
The purpose of this paper is multi-faceted: first, to analyze the impact of employee compensation and training on firms’ financial performance and the moderating effect of the COVID-19 pandemic on the relationship between employee compensation and financial performance, as well as the...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014284410
Saved in:
Cover Image
A a new digital value chain model with PLC in biopharmaceutical industry : the implication for open innovation
Kim, YongChan; Atukeren, Erdal; Lee, YeonWoo - In: Journal of open innovation : technology, market, and … 8 (2022) 2, pp. 1-18
The advancement of technology in the biopharmaceutical industry has spearheaded the speed and scale of digitalization in various aspects. New drug development is becoming more complex, costly, and challenging. This paper examines how the pharmaceutical value chain model could integrate with the...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013171458
Saved in:
Cover Image
The effect of marketing breadth and competitive spread on category growth
Xiang, Yi; Soberman, David A.; Gatignon, Hubert A. - In: Production and operations management : the flagship … 31 (2022) 2, pp. 622-644
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013163964
Saved in:
Cover Image
Many are called, few are chosen: the role of science in drug development decisions
Colen, Linde; Belderbos, René; Kelchtermans, Stijn; … - 2022
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013541933
Saved in:
Cover Image
Impact of pharmaceutical R&D activity on financial flexibility and bargaining power
Tömöri, Gergő; Bács, Zoltán; Felföldi, János; … - In: Economies : open access journal 10 (2022) 11, pp. 1-19
The specificities of pharmaceutical companies' activities also have an impact on their ability to improve profitability compared to other sectors. Examples of such specificities include patent rights on the medicines produced, which for a longer period of time prevent the entry of competing...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10013499483
Saved in:
Cover Image
Pharmaceutical consumption, economic growth and life expectancy in the OECD : the application of a new causal direction from dependency algorithm and a DeepNet process
Magazzino, Cosimo; Auteri, Monica; Schneider, Nicolas; … - In: Journal of economic studies 51 (2024) 9, pp. 249-271
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015198631
Saved in:
Cover Image
Pharmaceutical innovation collaboration, evaluation, and matching
Liu, Qianshuo - In: Journal of health economics 98 (2024), pp. 1-21
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015182090
Saved in:
Cover Image
Study of the mapping of pharmaceutical manufacturers in Korea for the Health Emergency Preparedness and Response Authority (HERA)
Health Emergency Preparedness and Response Authority; ICF - 2024
This analytical study provides a comprehensive overview of the pharmaceutical manufacturing landscape in South Korea, covering generics, vaccines, diagnostics, APIs, and PPE. The data is drawn from a total of 653 registered Korean pharmaceutical companies, with a focus on major players...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015320812
Saved in:
Cover Image
Reform of the EU's Pharma legislation : driving innovation for a competitive pharmaceutical industry
European Commission / Directorate-General for Health … - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015321267
Saved in:
Cover Image
Ex-post evaluation, EU competition enforcement and acquisitions of innovative competitors in the pharma sector leading to the discontinuation of overlapping drug research and development projects : final report and appendices
European Commission / Directorate-General for Competition; … - 2024
In recent years, concerns about transactions in the pharmaceutical sector harming innovation and competition through the discontinuation of overlapping drug R&D projects, so-called "killer acquisitions", have prompted regulatory action and research. The objective of this study is twofold. First,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015321498
Saved in:
Cover Image
Killer acquisitions
Guéron, Yves - In: Seoul journal of economics : SJE 37 (2024) 1, pp. 55-73
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015324277
Saved in:
Cover Image
The differential effects of sales control systems on salespeople’s role stressors and performance in the pharmaceutical industry
Cho, Yeonjin; Nam, Hyunjeong - In: The journal of business & industrial marketing 39 (2024) 13, pp. 108-127
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015205318
Saved in:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...